MGLL and cancer: Of these, CAT represents catalase, a key antioxidant enzyme which has been implicated in resistance to antileukemic agents such as doxorubicin [41], and MGLL (also known as MAGL) represents monoglyceride lipase, which has been shown to be overexpressed in aggressive cancers.